EQS-Adhoc: K+S Aktiengesellschaft: Non-cash impairment loss in consolidated balance sheet in accordance with IFRS

14.07.25 12:04 Uhr

Werte in diesem Artikel
Aktien

14,91 EUR -0,71 EUR -4,55%

EQS-Ad-hoc: K+S Aktiengesellschaft / Key word(s): Miscellaneous
K+S Aktiengesellschaft: Non-cash impairment loss in consolidated balance sheet in accordance with IFRS

14-Jul-2025 / 12:04 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Wer­bung


Requirement for a non-cash impairment loss in the K+S Group's consolidated balance sheet (IFRS) as of June 30, 2025 mainly due to the recent depreciation of the US dollar, but also because of changes in long-term potash price series and an increase in the cost of capital expected in the total amount of probably about EUR 2 billion 

While compiling the K+S Group's Half-Year Financial Report, a non-cash impairment loss on assets in the consolidated balance sheet (IFRS) was identified, totaling approximately EUR 2 billion. The impairment loss is mainly attributable to the increase in the long-term USD/EUR exchange rate assumption of USD 0.10 per EUR, but also to changed assumptions on long-term potash price series and an increase in the cost of capital. The future reaction of potash producers and customers to the depreciation of the US Dollar remains to be seen. These effects are not yet apparent in the price studies used by the Company for the impairment test. The impairment loss will correspondingly be recognized in the adjusted consolidated earnings after tax and will reduce the return on capital employed (ROCE). However, it will not result in any cash outflow. The preliminary book value per share after the impairment loss remains at over EUR 20 and thus significantly above the share price. Already in the past, the factors influencing the valuation in accordance with IAS 36 have been subject to considerable fluctuations in both directions. Therefore, sensitivity calculations are published in the K+S Group's Annual Reports to demonstrate their effects.

Based on the current assumptions, there will be no significant depreciations and amortizations and other reductions in earnings arising from transfer of losses through value adjustments at K+S Aktiengesellschaft subsidiaries in the individual financial statements (HGB) as of December 31, 2025. From today’s perspective, the above-mentioned developments, therefore, have no effects that jeopardize the Company's ability to pay dividends.

The closing of accounts is still ongoing. The Company will publish its H1/2025 Half-Year Financial Report on August 12, 2025.
Contact:
Investor Relations:
Julia Bock
Phone: +49 561 9301-1009
julia.bock@k-plus-s.com


End of Inside Information

14-Jul-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: K+S Aktiengesellschaft
Bertha-von-Suttner-Str. 7
34131 Kassel
Germany
Phone: +49 561 9301 0
Fax: +49 561 9301 2425
E-mail: investor-relations@k-plus-s.com
Internet: www.k-plus-s.com
ISIN: DE000KSAG888
WKN: KSAG88
Indices: MDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich, Stuttgart; Regulated Unofficial Market in Tradegate Exchange
EQS News ID: 2169242

 
End of Announcement EQS News Service

Wer­bung

2169242  14-Jul-2025 CET/CEST

Ausgewählte Hebelprodukte auf K+S

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf K+S

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu K+S AG

Wer­bung

Analysen zu K+S AG

DatumRatingAnalyst
26.06.2025K+S BuyWarburg Research
17.06.2025K+S BuyWarburg Research
10.06.2025K+S NeutralJP Morgan Chase & Co.
04.06.2025K+S SellDeutsche Bank AG
26.05.2025K+S SellUBS AG
DatumRatingAnalyst
26.06.2025K+S BuyWarburg Research
17.06.2025K+S BuyWarburg Research
15.05.2025K+S BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
13.05.2025K+S AddBaader Bank
07.05.2025K+S AddBaader Bank
DatumRatingAnalyst
10.06.2025K+S NeutralJP Morgan Chase & Co.
26.05.2025K+S HoldWarburg Research
14.05.2025K+S HaltenDZ BANK
13.05.2025K+S NeutralJP Morgan Chase & Co.
30.04.2025K+S HaltenDZ BANK
DatumRatingAnalyst
04.06.2025K+S SellDeutsche Bank AG
26.05.2025K+S SellUBS AG
16.05.2025K+S UnderperformJefferies & Company Inc.
15.05.2025K+S SellUBS AG
14.05.2025K+S SellDeutsche Bank AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für K+S AG nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen